Therefore, taking advantage of the upregulated expression of DLAT, supported by glycolysis inhibitors, and using copper carriers to induce cuproptosis in GC cells may become a potentially promising tumor therapeutic strategy. The gene discussed is DLAT; the disease is gastric cancer.